Outpatient Costs of Medications for Patients with Chronic Heart Failure

Skip Nav Destination

Am J Crit Care (2002) 11 (5): 474–478.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective

Oussama Wazni
Joe Moss
Malte Kuniss
Jason Andrade
Gian Battista Chierchia
Stuart Mealing
Waruiru Mburu
Alicia Sale
Rachelle Kaplon
Eleni Ismyrloglou
Tom Bromilow
Emily Lane
Damian Lewis
Matthew R. Reynolds

Heart Rhythm O2 (2023) 4 (9): 528.

The ABC Analysis of Drug Use and Cost in Cardiology Outpatients -National Health Insurance

Budi Suprapti
M. Yusuf
Marcha Debby Saraswati
Selvia Febriana Astuti
Dewi Damayanti

JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA (2022) 9 (2): 193.

Systematic Review and Meta-analysis of Pharmacist-Led Transitions of Care Services on the 30-Day All-Cause Readmission Rate of Patients with Congestive Heart Failure

Connor McKay
Chanhyun Park
Jongwha Chang
Marcia Brackbill
Jae-Young Choi
Jung Heon Lee
Sean Hyungwoo Kim

Clinical Drug Investigation (2019) 39 (8): 703.

Accuracy of medication lists on general practitioner referral letters to emergency departments for patients with congestive cardiac failure compared with other polypharmacy patients

Thomas J. S. Harwood
Richard J. Paoloni
Sultana S. Mitic

Journal of Pharmacy Practice and Research (2015) 45 (3): 291.

The influence of the human microbiome and probiotics on cardiovascular health

Grace Ettinger
Kyle MacDonald
Gregor Reid
Jeremy P Burton

Gut Microbes (2014) 5 (6): 719.

A Reevaluation of the Costs of Heart Failure and Its Implications for Allocation of Health Resources in the United States

Jeff Voigt
M. Sasha John
Andrew Taylor
Mitchell Krucoff
Matthew R. Reynolds
C. Michael Gibson

Clinical Cardiology (2014) 37 (5): 312.

Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study

Giovanni Pulignano
Donatella Del Sindaco
Andrea Di Lenarda
Luigi Tarantini
Giovanni Cioffi
Dario Gregori
Maria Denitza Tinti
Luca Monzo
Giovanni Minardi

Journal of Cardiovascular Medicine (2010) 11 (10): 739.

Testing the psychometric properties of the Medication Adherence Scale in patients with heart failure

Jia-Rong Wu
Misook Chung
Terry A. Lennie
Lynne A. Hall
Debra K. Moser

Heart & Lung (2008) 37 (5): 334.

Predictors of Medication Adherence Using a Multidimensional Adherence Model in Patients With Heart Failure

Jia-Rong Wu
Debra K. Moser
Misook L. Chung
Terry A. Lennie

Journal of Cardiac Failure (2008) 14 (7): 603.

Improving Medication Adherence in Chronic Cardiovascular Disease

Nancy M. Albert

Critical Care Nurse (2008) 28 (5): 54.

Patient-Reported Economic Burden and the Health Status of Heart Failure Patients

Mark W. Conard
Paul Heidenreich
John S. Rumsfeld
William S. Weintraub
John Spertus

Journal of Cardiac Failure (2006) 12 (5): 369.

Cost-of-Illness Studies

Ebere Akobundu
Jing Ju
Lisa Blatt
C Daniel Mullins

PharmacoEconomics (2006) 24 (9): 869.

Remote Physiological Monitoring: Clinical, Financial, and Behavioral Outcomes in a Heart Failure Population

Laurel R. Hudson
G. Brent Hamar
Patty Orr
Jeffrey H. Johnson
Amy Neftzger
Richard S. Chung
Myra L. Williams
William M. Gandy
Albert Crawford
Janice Clarke
Neil I. Goldfarb

Disease Management (2005) 8 (6): 372.

Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: A budget impact analysis

Dean G. Smith
Annamaria Cerulli
Feride H. Frech

Clinical Therapeutics (2005) 27 (6): 951.

Anesthesiology: perioperative medicine or “when the anesthetic is a diuretic”

Sno E White
Timothy E Morey

Journal of Clinical Anesthesia (2004) 16 (2): 130.

Outpatient Costs of Medications for Patients with Chronic Heart Failure

JOURNALS

This Feature Is Available To Subscribers Only